These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist. Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651 [TBL] [Abstract][Full Text] [Related]
27. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies. Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150 [TBL] [Abstract][Full Text] [Related]
28. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1. Davis CN; Zujovic V; Harrison JK Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546 [TBL] [Abstract][Full Text] [Related]
29. Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10). Crump MP; Elisseeva E; Gong J; Clark-Lewis I; Sykes BD FEBS Lett; 2001 Feb; 489(2-3):171-5. PubMed ID: 11165244 [TBL] [Abstract][Full Text] [Related]
30. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499 [TBL] [Abstract][Full Text] [Related]
31. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication. Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095 [TBL] [Abstract][Full Text] [Related]
32. Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development. Singh S; Malik BK; Sharma DK Chem Biol Drug Des; 2007 Mar; 69(3):191-203. PubMed ID: 17441905 [TBL] [Abstract][Full Text] [Related]
33. HIV chemokine receptor inhibitors as novel anti-HIV drugs. Princen K; Schols D Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254 [TBL] [Abstract][Full Text] [Related]
34. Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency Virus (HIV) type 1 replication but not HIV entry into human monocytes. Creery D; Weiss W; Graziani-Bowering G; Kumar R; Aziz Z; Angel JB; Kumar A Viral Immunol; 2006; 19(3):409-23. PubMed ID: 16987060 [TBL] [Abstract][Full Text] [Related]
35. Structural and Biological Characterizations of Novel High-Affinity Fluorescent Probes with Overlapped and Distinctive Binding Regions on CXCR4. Zhu S; Meng Q; Schooley RT; An J; Xu Y; Huang Z Molecules; 2019 Aug; 24(16):. PubMed ID: 31412600 [TBL] [Abstract][Full Text] [Related]
36. Peptide-lead CXCR4 antagonists with high anti-HIV activity. Fujii N; Tamamura H Curr Opin Investig Drugs; 2001 Sep; 2(9):1198-202. PubMed ID: 11717804 [TBL] [Abstract][Full Text] [Related]